PAIN MEDICATION

TESTING |  WHY & WHEN  |  PANELS
MYTHS & FACTS | SAMPLES

PANELS

Both the qualitative and quantitative panel include:

            Validity testing (Creatinine, pH, Oxidants and Specific Gravity)

            Methamphetamine (150 ng/mL)               Amphetamine (150 ng/mL)
            MDMA (150 ng/mL)                                 MDA (150 ng/mL)
            Phentermine (150 ng/mL)                        Phenylpropanolamine (150 ng/mL)
            Ephedrine/Pseudoephedrine (150 ng/mL)

            α – Hydroxyalprazolam (25 ng/mL)          Chlordiazepoxide (100 ng/mL)
            Clorazepate (100 ng/mL)                          Diazepam      (100 ng/mL)
            Flurazepam  (100 ng/mL)                          Lorazepam (100 ng/mL)
            Oxazepam (100 ng/mL)                            Temazepam (100 ng/mL)

            Codeine (60 ng/mL)                                   Dihydrocodone (60 ng/mL)
            Hydrocodone (60 ng/mL)                          Hydromorphone (60 ng/mL)
            Oxycodone (60 ng/ml)                              Oxymorphone (60 ng/mL)
            Morphine (30 ng/mL)

            Methadone (150 ng/mL)                             EDDP (150 ng/mL)

            Propoxyphene (150 ng/mL)                       Norpropoxyphene (150 ng/mL)

            Buprenorphine (50 ng/mL)                         Norbuprenorphine (50 ng/mL)

            Fentanyl (0.5 ng/mL)                                  Norfentanyl (0.5 ng/mL)

            Carisoprodol (500 ng/mL)                          Meprobamate (500 ng/mL)

            Benzoylecgonine (15 ng/mL)
           
            Δ- 9-11-nor-CarboxyTHC (4.5 ng/mL)

            Phencyclidine (2.5 ng/mL)

            Ethanol (20 mg/dL)

 

Additional compounds of interest may be requested.